| WKN: | 813534 |
| ISIN: | US1167941087 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Bruker-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 21. November 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2009 | 2,57 | 8,29 | 222,57% |
| 2 | 2019 | 24,80 | 45,40 | 83,06% |
| 3 | 2021 | 43,40 | 73,50 | 69,35% |
| 4 | 2007 | 5,68 | 8,90 | 56,69% |
| 5 | 2010 | 8,29 | 12,55 | 51,39% |
| 6 | 2015 | 16,03 | 22,92 | 42,98% |
| 7 | 2017 | 19,95 | 28,25 | 41,60% |
| 8 | 2006 | 4,10 | 5,68 | 38,54% |
| 9 | 2005 | 3,02 | 4,10 | 35,76% |
| 10 | 2013 | 11,36 | 14,51 | 27,73% |
| 11 | 2012 | 9,51 | 11,36 | 19,45% |
| 12 | 2014 | 14,51 | 16,03 | 10,48% |
| 13 | 2023 | 64,50 | 66,50 | 3,10% |
| 14 | 2020 | 45,40 | 43,40 | -4,41% |
| 15 | 2018 | 28,25 | 24,80 | -12,21% |
| 16 | 2022 | 73,50 | 64,50 | -12,24% |
| 17 | 2016 | 22,92 | 19,95 | -12,96% |
| 18 | 2004 | 3,55 | 3,02 | -14,93% |
| 19 | 2024 | 66,50 | 55,60 | -16,39% |
| 20 | 2011 | 12,55 | 9,51 | -24,22% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2002 | 17,00 | 4,80 | -71,76% |
| 2 | 2008 | 8,90 | 2,57 | -71,12% |
| 3 | 2025 | 55,60 | 37,69 | -32,21% |
| 4 | 2001 | 23,00 | 17,00 | -26,09% |
| 5 | 2003 | 4,80 | 3,55 | -26,04% |
| 6 | 2011 | 12,55 | 9,51 | -24,22% |
| 7 | 2024 | 66,50 | 55,60 | -16,39% |
| 8 | 2004 | 3,55 | 3,02 | -14,93% |
| 9 | 2016 | 22,92 | 19,95 | -12,96% |
| 10 | 2022 | 73,50 | 64,50 | -12,24% |
| 11 | 2018 | 28,25 | 24,80 | -12,21% |
| 12 | 2020 | 45,40 | 43,40 | -4,41% |
| 13 | 2023 | 64,50 | 66,50 | 3,10% |
| 14 | 2014 | 14,51 | 16,03 | 10,48% |
| 15 | 2012 | 9,51 | 11,36 | 19,45% |
| 16 | 2013 | 11,36 | 14,51 | 27,73% |
| 17 | 2005 | 3,02 | 4,10 | 35,76% |
| 18 | 2006 | 4,10 | 5,68 | 38,54% |
| 19 | 2017 | 19,95 | 28,25 | 41,60% |
| 20 | 2015 | 16,03 | 22,92 | 42,98% |